CTAS Remains Committed To Cost Cutting, Enhancing Cash Flows
Analyst John Healy of Northcoast Research maintains his "buy" rating on Cintas (NASDAQ: CTAS). The target price for CTAS is set to $32.
Cintas has indicated that its top-line growth will be linked to the economic recovery, which is expected to be a slow and gradual process. “CTAS believes that over the long-run the company should be able to generate low double digit revenue growth and meaningful operating leverage which should allow for earnings growth to outpace top-line growth,” the analyst says.
“CTAS appears poised to continue to maintain a strong balance sheet in the near-term with the goal of remaining flexible for both small and large acquisition opportunities that may present themselves to the company,” the analyst adds.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
